Dr. Hartley-Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Ste 1
Boston, MA 02215Phone+1 617-632-3823Fax+1 617-582-8608
Summary
- Dr. Monique Hartley-Brown is a Hematologic oncologist in Long Island, NY and is affiliated with multiple hospitals in the area, including Long Island Jewish Medical Center and North Shore University Hospital. She received her medical degree from NYU School of Medicine and has been in practice 13 years. She specializes in Multiple Myeloma and plasma cell dyscrasias and is well experienced in hematologic oncology.
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
New York University School of MedicineClass of 2004
Certifications & Licensure
MA State Medical License 2021 - 2026
RI State Medical License 2022 - 2026
NY State Medical License 2006 - 2025
MT State Medical License 2021 - 2023
FL State Medical License 2007 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parameters.Lauren Merz, Monique Hartley-Brown, Maureen Achebe, Craig Cole, Bindu Kanapuru
Seminars in Hematology. 2024-10-25 - Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidence.Monique A Hartley-Brown, Katja Weisel, Jacopo Bitetti, John A Carter, Simon McNamara
British Journal of Haematology. 2024-09-01 - 1 citationsTargeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide.Yuxin Liu, Clifton C Mo, Monique A Hartley-Brown, Adam S Sperling, Shonali Midha
Expert Review of Hematology. 2024-08-01
Press Mentions
International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific AssemblyAugust 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
